Eyenovia, Inc.
Eyenovia, Inc. (EYEN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
eyen · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Eyenovia, Inc. (EYEN) measures how much investors pay for each dollar of the company's trailing earnings. EYEN's current PE ratio of N/A is calculated by dividing its stock price of $7.56 by its TTM earnings per share of -$3.11.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2015 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Eyenovia, Inc.You EYEN | $39M | N/A | — | -$3.11 |
 Cerecor Inc. CERC | $39M | N/A | — | -$5.84 |
 GreenLight Biosciences Holdings GRNA | $45M | N/A | — | -$1.27 |
 LianBio LIANY | $12M | 2.11x | — | $0.05 |
 Lumos Pharma, Inc. LUMO | $38M | N/A | — | -$4.18 |
 Magenta Therapeutics, Inc. MGTA | $42M | N/A | — | $0.00 |
 Marinus Pharmaceuticals, Inc. MRNS | $30M | N/A | — | -$2.63 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $0.00 | — | |
2024-12-31 FY2024 | — | $-59.81 | — | |
2023-12-31 FY2023 | — | $-44.29 | — | |
2022-12-31 FY2022 | — | $-54.94 | — | |
2021-12-31 FY2021 | — | $-32.36 | — | |
2020-12-31 FY2020 | — | $-62.35 | — | |
2019-12-31 FY2019 | — | $-97.51 | — | |
2018-12-31 FY2018 | — | $-121.37 | — | |
2017-12-31 FY2017 | — | $-34.42 | — | |
2016-12-31 FY2016 | — | $-23.71 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Eyenovia, Inc. (EYEN) measures how much investors pay for each dollar of the company's trailing earnings. EYEN's current PE ratio of N/A is calculated by dividing its stock price of $7.56 by its TTM earnings per share of -$3.11.
Frequently asked questions
EYEN pe ratio · 6 questionsEYEN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $7.56 and TTM EPS of -$3.11. Data sourced from Financial Modeling Prep via EYEN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Eyenovia, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09